A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial

Clinical trial NCT07227103 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07227103
Sponsor: NeuroRx, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Treatment Resistant Depression Treatment Resistant Depression (TRD)

Start date: 2026-09-01
Primary completion: 2027-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.